Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

dexamethasone intravitreal implant

An intravitreal implant containing the corticosteroid dexamethasone embedded in a biodegradable polymer matrix, with anti-inflammatory and macular edema-relieving activity. Upon insertion into the vitreous cavity, dexamethasone intravitreal implant is dissolved slowly and dexamethasone is released over an extended period of time. Dexamethasone inhibits inflammation thereby preventing leakage from the capillaries and a reduction of retinal edema. This may ultimately prevent vision impairment.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Ozurdex
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search